248 related articles for article (PubMed ID: 17679827)
1. Role of home blood pressure and ambulatory blood pressure monitoring in decisions of when and whom to treat: recommendations for practicing clinicians.
Ogedegbe G
J Cardiometab Syndr; 2006; 1(3):222-4. PubMed ID: 17679827
[No Abstract] [Full Text] [Related]
2. Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):146-8. PubMed ID: 17679828
[TBL] [Abstract][Full Text] [Related]
3. Management of hypertension in children and adolescents with the metabolic syndrome.
Puri M; Flynn JT
J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
[TBL] [Abstract][Full Text] [Related]
4. PREFACE: "The Lower the Better" Association between White-coat Effect-excluded Blood Pressure and Cardiovascular Events in High-risk Hypertension: Insights from SPRINT.
Kario K
Curr Hypertens Rev; 2016; 12(1):2-10. PubMed ID: 26983556
[No Abstract] [Full Text] [Related]
5. Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention.
Karmali KN; Lloyd-Jones DM
Hypertension; 2017 Mar; 69(3):e2-e9. PubMed ID: 28115516
[No Abstract] [Full Text] [Related]
6. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
Basile J; Houston M; Ferrario CM
J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
[No Abstract] [Full Text] [Related]
7. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
8. Some thoughts about recent hypertension trials.
Conti CR
Clin Cardiol; 2007 Jun; 30(6):268-70. PubMed ID: 17551957
[No Abstract] [Full Text] [Related]
9. Early detection and management of the high-risk patient with elevated blood pressure.
Sierra C; de la Sierra A
Vasc Health Risk Manag; 2008; 4(2):289-96. PubMed ID: 18561504
[TBL] [Abstract][Full Text] [Related]
10. Emerging Concepts in the Diagnosis and Treatment of Hypertension in the SPRINT Era.
Phillips RA
Methodist Debakey Cardiovasc J; 2015; 11(4):204-5. PubMed ID: 27057287
[No Abstract] [Full Text] [Related]
11. Non-dipping status in arterial hypertension: an overview.
Sarigianni M; Dimitrakopoulos K; Tsapas A
Curr Vasc Pharmacol; 2014 May; 12(3):527-36. PubMed ID: 23016964
[TBL] [Abstract][Full Text] [Related]
12. Can the effectiveness of hypertension management be improved?
Ruilope LM
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):689-95. PubMed ID: 23750678
[TBL] [Abstract][Full Text] [Related]
13. Differential Approaches are Much Needed for "Real World" Management of Hypertension in the Era of "Hypertension Paradox".
Kario K
Curr Hypertens Rev; 2018; 14(1):2-5. PubMed ID: 29943699
[No Abstract] [Full Text] [Related]
14. Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy: the CHECK Study.
Filippi A; Casula M; Tragni E; Brignoli O; Cricelli C; Poli A; Catapano AL;
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):562-8. PubMed ID: 20308908
[TBL] [Abstract][Full Text] [Related]
15. Are guidelines effectively guiding antihypertensive therapy?
Vasan RS; Kannel WB
Am J Cardiol; 2007 Jul; 100(1):143-4. PubMed ID: 17599457
[No Abstract] [Full Text] [Related]
16. Hypertension goals in advanced-stage kidney disease.
Hopkins K; Bakris GL
Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S92-4. PubMed ID: 19996011
[TBL] [Abstract][Full Text] [Related]
17. Implementation of shared decision making by physician training to optimise hypertension treatment. Study protocol of a cluster-RCT.
Tinsel I; Buchholz A; Vach W; Siegel A; Dürk T; Loh A; Buchholz A; Niebling W; Fischer KG
BMC Cardiovasc Disord; 2012 Sep; 12():73. PubMed ID: 22966894
[TBL] [Abstract][Full Text] [Related]
18. Annual influenza immunization: as important as control of blood pressure and cholesterol as secondary prevention for cardiovascular disease.
Grajewski J; Slusar M; Hayney MS
J Am Pharm Assoc (2003); 2007; 47(5):662-3. PubMed ID: 17848356
[No Abstract] [Full Text] [Related]
19. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
[TBL] [Abstract][Full Text] [Related]
20. [New guidelines 2007 for the management of arterial hypertension].
Krzesinski JM; Xhignesse P
Rev Med Liege; 2007 Sep; 62(9):566-74. PubMed ID: 17966793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
